Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Inotiv Inc.

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Inotiv, with a price target of $5.00. Takkinen covers the He...

Lake Street Keeps Their Buy Rating on Inotiv (NOTV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inotiv (NOTV – Research Report) and Exagen (XGN – Re...

Current Quarter	$NA	Next Quarter	$NA
Current Year	$NA	Next Year	$NA
QoQ Growth	NaN%	YoY Growth	NaN%
3Y EPS CAGR	-91.7%	Target Price	$5.50
Consensus	Buy	Upside	+568.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NOTV	$0.82	-3.89%	740.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NOTV	$0.82	-3.9%	740.47K
3
4
5
6

NOTV

NOTV

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Inotiv Inc. Data in Excel

Get Inotiv Inc. Data in Excel